Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$3.27 - $8.76 $7,906 - $21,181
-2,418 Closed
0 $0
Q1 2022

Jun 20, 2023

BUY
$7.56 - $14.3 $18,280 - $34,577
2,418 New
2,418 $19,000
Q1 2022

Mar 30, 2023

SELL
$7.56 - $14.3 $56,246 - $106,392
-7,440 Reduced 75.47%
2,418 $19,000
Q1 2022

May 12, 2022

SELL
$7.56 - $14.3 $56,246 - $106,392
-7,440 Reduced 75.47%
2,418 $20,000
Q4 2021

Jun 21, 2023

BUY
$12.24 - $21.25 $120,661 - $209,482
9,858 New
9,858 $140,000
Q4 2021

Mar 30, 2023

SELL
$12.24 - $21.25 $4,773 - $8,287
-390 Reduced 3.81%
9,858 $140,000
Q4 2021

Feb 15, 2022

SELL
$12.24 - $21.25 $4,773 - $8,287
-390 Reduced 3.81%
9,858 $141,000
Q3 2021

Jun 21, 2023

BUY
$16.69 - $26.05 $171,039 - $266,960
10,248 New
10,248 $197,000
Q2 2021

Jun 21, 2023

BUY
$18.15 - $27.75 $186,001 - $284,382
10,248 New
10,248 $259,000
Q2 2021

Mar 30, 2023

BUY
$18.15 - $27.75 $66,247 - $101,287
3,650 Added 55.32%
10,248 $259,000
Q2 2021

Aug 16, 2021

BUY
$18.15 - $27.75 $185,874 - $284,187
10,241 Added 146300.0%
10,248 $259,000
Q1 2021

Jun 26, 2023

BUY
$20.71 - $51.02 $136,644 - $336,629
6,598 New
6,598 $162 Million
Q1 2021

May 14, 2021

SELL
$20.71 - $51.02 $136,499 - $336,272
-6,591 Reduced 99.89%
7 $162,000
Q4 2020

Jun 22, 2023

BUY
$21.84 - $44.0 $144,100 - $290,312
6,598 New
6,598 $241,000
Q3 2020

Jun 26, 2023

BUY
$13.63 - $24.12 $89,930 - $159,143
6,598 New
6,598 $142,000
Q2 2020

Jun 26, 2023

BUY
$7.65 - $14.11 $50,474 - $93,097
6,598 New
6,598 $85,000
Q2 2020

Mar 30, 2023

BUY
$7.65 - $14.11 $50,474 - $93,097
6,598 New
6,598 $85,000
Q2 2020

Aug 14, 2020

BUY
$7.65 - $14.11 $50,474 - $93,097
6,598 New
6,598 $86,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $226M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.